Skip to content

Study · Measured the body's own peptide · 2006

2 results

In vivo detection of secreted proteins from wounded skin using capillary ultrafiltration probes and mass spectrometric proteomics.

Huang CM, Wang CC, Barnes S, Elmets CA

Proteomics1 Nov 2006Cited by 39 (Europe PMC)

PMID17001601 (opens in a new tab)DOI10.1002/pmic.200600163 (opens in a new tab)PepBankPUB-17001601
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01AnimalEndogenous levelOther designOther

    Mass spectrometry of in vivo skin wound fluid identified a 1694.8 Da peptide of the body's own thymosin beta4.

    In plain wordsIn wounded skin fluid, the body's own thymosin beta4 was detected as a fragment by mass spectrometry.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    Not applicableThymosin beta4 fragment in skin wound fluid
    Study

    n: not reported in source

    Outcome group
    Wound healing · Skin and wound

    Measurements

    fragment mass
    1694.8 Da
    thymosin beta4 fragment

    Source sentences

    Summary
    Two protein fragments with masses of 1565.7 and 1694.8 Da were identified by MS as peptides of thymosin beta10 and beta4, respectively.

    This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.

Studies that did not test the peptide alone1

In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymosin beta-4 (human).

  1. 02AnimalNot a test of Thymosin beta-4 (human) aloneOther designEfficacy outcome

    The LKKTETQ peptide, an actin-binding domain shared by thymosin beta4 and beta10, enhanced skin wound healing in vitro and in vivo.

    In plain wordsIn lab and animal tests, a short peptide fragment shared by thymosin beta4 and beta10 helped skin wounds heal.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    IncreaseSkin wound healing with LKKTETQ peptide
    Study

    n: not reported in source

    Outcome group
    Wound healing · Skin and wound

    Source sentences

    Summary
    The LKKTETQ peptide, a common actin-binding domain of thymosin beta4 and beta10, significantly enhanced skin wound healing in vitro and in vivo.

    In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin beta-4 (human).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.